Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
about
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basisMechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersAntihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.The Pharmacogenomics of Anti-Hypertensive TherapyDo genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin systemDeterminants of plasma renin activity: role of a human renin gene variant as a genetic factor.Ethnic differences in cardiovascular drug response: potential contribution of pharmacogeneticsHow to assess the external validity of therapeutic trials: a conceptual approach.Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient.Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
P2860
Q24655643-7D1F862B-B964-43C2-9013-74E2BA239AF8Q26753129-91FE32CC-E24E-49EE-A0C0-DB39E0C980F9Q33561456-0F8F00CF-A842-4123-8D61-A76AF07E3E65Q33567530-CD87CAD7-073F-4990-9BB5-08331D515002Q33664144-846CD78B-8EE6-4ED4-BFAF-D59A641DF7E7Q35230775-E6CC5B38-E1C0-454B-8491-0D84F6927E7FQ36151790-1AD031A7-7F8E-4347-A4D6-81DE97AE55F8Q37276490-06D36459-F800-4ED1-A3BD-0057E80AD362Q37450517-07CFA34D-6DA6-4BB0-AC28-BFF612717594Q38371163-B838FBA4-5B70-418E-AE8F-BA300EDFD260Q47137466-7C276082-F623-48D5-ADE9-607B58834AD1
P2860
Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors influencing blood pres ...... /Trandolapril [INVEST] Study).
@en
Factors influencing blood pres ...... n patients taking verapamil SR
@nl
type
label
Factors influencing blood pres ...... /Trandolapril [INVEST] Study).
@en
Factors influencing blood pres ...... n patients taking verapamil SR
@nl
prefLabel
Factors influencing blood pres ...... /Trandolapril [INVEST] Study).
@en
Factors influencing blood pres ...... n patients taking verapamil SR
@nl
P2093
P2860
P1476
Factors influencing blood pres ...... /Trandolapril [INVEST] Study).
@en
P2093
Carl J Pepine
INVEST Investigators
Jason H Karnes
Julie A Johnson
Martin Brunner
Rhonda M Cooper-DeHoff
Taimour Y Langaee
P2860
P304
P356
10.1016/J.AMJCARD.2007.01.029
P407
P577
2007-04-16T00:00:00Z